DuPont de Nemours, Inc. Other Income (Expense) increased by 50.0% to $36.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 64.0%, from $100.00M to $36.00M. Over 2 years (FY 2021 to FY 2024), Other Income (Expense) shows a downward trend with a -16.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $135.00M | $1.00M | $0.00 | $3.00M | $94.00M | $26.00M | $68.00M | $29.00M | $28.00M | $55.00M | $38.00M | -$87.00M | $200.00M | -$258.00M | $100.00M | -$13.00M | $24.00M | $36.00M |
| QoQ Change | — | -99.3% | -100.0% | — | >999% | -72.3% | +161.5% | -57.4% | -3.4% | +96.4% | -30.9% | -328.9% | +329.9% | -229.0% | +138.8% | -113.0% | +284.6% | +50.0% |
| YoY Change | — | — | — | — | -30.4% | >999% | — | +866.7% | -70.2% | +111.5% | +31.0% | -410.7% | +263.6% | — | +163.2% | +85.1% | -88.0% | -64.0% |